FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could help bring the world closer to ending the decades-long epidemic caused by the virus.  But the launch of the injectable drug, which will be marketed under the name Yeztugo, … Read more

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering Love Employee | Istock | Getty Images Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its … Read more

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead … Read more

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave … Read more

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S.  Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% … Read more

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Trump’s tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated … Read more